407 A Broad Tumor Cell Line Panel Screen of Ponatinib, a Pan-BCR-ABL and Multitargeted Kinase Inhibitor
Gozgit, J, Chen, T, Schrock, A, Clackson, T, Rivera, V.M
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
3061 Assessment of Brigatinib (AP26113) CNS Activity in Patients (Pts) With ALK+ NSCLC and intracranial metastases in a Phase 1/2 Study
Camidge, D.R, Bazhenova, L.A, Salgia, R, Langer, C.J, Gold, K, Rosell, R, Shaw, A.T, Weiss, G.J, Dorer, D.J, Rivera, V.M, Conlan, M.G, Kerstein, D, Gettinger, S.N
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Patient/Doctor Talk Time During High-Quality in Advanced Heart Failure Indicative of Doctor’s Perception of How Well Patient Is Doing
Raia, F, Robinson, L, Lee, S, Alvarenga, C, Rivera, V.M, Nguyen, D, Mistry, J.S, Tellez, G, Garfinkel, A, Deng, M
Published in The Journal of heart and lung transplantation (01.04.2015)
Published in The Journal of heart and lung transplantation (01.04.2015)
Get full text
Journal Article
56 Efficacy and safety of brigatinib (AP26113) in ALK+ NSCLC: phase 1/2 trial results
Gettinger, S.N, Bazhenova, L.A, Salgia, R, Langer, C.J, Gold, K, Rosell, R, Shaw, A.T, Weiss, G.J, Dorer, D.J, Rivera, V.M, Kerstein, D, Camidge, D.R
Published in Lung cancer (Amsterdam, Netherlands) (2016)
Published in Lung cancer (Amsterdam, Netherlands) (2016)
Get full text
Journal Article
164 The Dual ALK/EGFR Inhibitor AP26113 Also Potently Inhibits
Anjum, R, Zhang, S, Squillace, R, Clackson, T, Garner, A.P, Rivera, V.M
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
81: Efficacy and safety of AP26113 in ALK+ non-small cell lung cancer (NSCLC), including patients with brain metastases
Gettinger, S.N, Bazhenova, L, Salgia, R, Langer, C.J, Gold, K.A, Rosell, R, Shaw, A.T, Weiss, G.J, Narasimhan, N.I, Dorer, D.J, Rivera, V.M, Clackson, T, Haluska, F.G, Camidge, D.R
Published in Lung cancer (Amsterdam, Netherlands) (2015)
Published in Lung cancer (Amsterdam, Netherlands) (2015)
Get full text
Journal Article
Control strategies and experimental validation for high-gain non-isolated double inductor boost converter
Reyes-Cruz, D., Martinez-Rodriguez, P.R., Langarica-Cordoba, D., Vazquez-Guzman, G., Sosa-Zuñiga, J.M., Ramirez-Rivera, V.M.
Published in Engineering science and technology, an international journal (01.01.2023)
Published in Engineering science and technology, an international journal (01.01.2023)
Get full text
Journal Article
1101 POSTER Identification of KRas Mutational Polymorphism by Molecular Analysis Using High-resolution Melting System in a Large MCRC Mexican Sample
Vega, H. Astudillo-de la, Romero-Garcia, P, Silva, J.A, Villalobos-Valencia, R, Vazquez-Rivera, V.M, Ruiz-Calzada, H, Lopez-Yañez, A, Cortes-Esteban, P, Calderillo-Ruiz, G, Ruiz-Garcia, E
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias
Cortes, J.E, Kim, D.-W, Pinilla-Ibarz, J, le Coutre, P, Paquette, R, Chuah, C, Nicolini, F.E, Apperley, J.F, Khoury, H.J, Talpaz, M, DiPersio, J, DeAngelo, D.J, Abruzzese, E, Rea, D, Baccarani, M, Müller, M.C, Gambacorti-Passerini, C, Wong, S, Lustgarten, S, Rivera, V.M, Clackson, T, Turner, C.D, Haluska, F.G, Guilhot, F, Deininger, M.W, Hochhaus, A, Hughes, T, Goldman, J.M, Shah, N.P, Kantarjian, H
Published in The New England journal of medicine (07.11.2013)
Published in The New England journal of medicine (07.11.2013)
Get full text
Journal Article
553 POSTER AP24534: an orally active kinase inhibitor that targets multiple pro-angiogenic receptors and exhibits potent anti-tumor activity in vivo
Rivera, V.M, DiRenzo, R, Berk, L, Wardwell, S, Ning, Y, Narasimhan, N.I, Xu, Q, Shakespeare, W.C, Wang, F, Clackson, T
Published in European journal of cancer supplements (2008)
Published in European journal of cancer supplements (2008)
Get full text
Journal Article
321 POSTER A phase I trial evaluating pharmacodynamics of deforolimus (AP23573, MK-8669) delivered orally on multiple dosing schedules
Berk, L, Miller, D, Clapham, D, Loewy, J, Mita, M, Britten, C, Poplin, E, Bedrosian, C.L, Clackson, T, Rivera, V.M
Published in European journal of cancer supplements (2008)
Published in European journal of cancer supplements (2008)
Get full text
Journal Article
195 POSTER Pharmacogenomic analysis of the peripheral blood cell transcriptome in patients with advanced solid tumors treated with the mTOR inhibitor deforolimus (AP23573; MK 8669) in phase Ib studies
Rinaldi, A, Kwee, I, Bertoni, F, Viganò, L, Hess, D, Coceani, N, Sessa, C, Rivera, V.M, Bedrosian, C.L, Catapano, C.V
Published in European journal of cancer supplements (2008)
Published in European journal of cancer supplements (2008)
Get full text
Journal Article
Brigatinib (BRG) in anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC): Long-term efficacy and safety results from a phase 1/2 trial
Bazhenova, L.A., Gettinger, S.N., Langer, C.J., Salgia, R., Gold, K.A., Rosell, R., Shaw, A.T., Weiss, G.J., Haney, J., Rivera, V.M., Kerstein, D., Camidge, R.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Phase 2 Study of Ponatinib in Patients (Pts) with Advanced Gastrointestinal Stromal Tumors (Gist) After Failure of Tyrosine Kinase Inhibitor (Tki) Therapy: Early Results
Heinrich, M.C., von Mehren, M., Demetri, G.D., Fletcher, J., Sun, J., Hodgson, J.G., Rivera, V.M., Turner, C.D., George, S.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
1417PDPHASE 2 STUDY OF PONATINIB IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER FAILURE OF TYROSINE KINASE INHIBITOR (TKI) THERAPY: EARLY RESULTS
Heinrich, M.C., von Mehren, M., Demetri, G.D., Fletcher, J., Sun, J., Hodgson, J.G., Rivera, V.M., Turner, C.D., George, S.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarcoma
Mita, M.M., Poplin, E., Britten, C.D., Tap, W.D., Rubin, E.H., Scott, B.B., Berk, L., Rivera, V.M., Loewy, J.W., Dodion, P., Haluska, F., Sarantopoulos, J., Mita, A., Tolcher, A.
Published in Annals of oncology (01.04.2013)
Published in Annals of oncology (01.04.2013)
Get full text
Journal Article
Alk Inhibitor Ap26113 in Patients with Advanced Malignancies, Including Alk+ Non-Small Cell Lung Cancer (Nsclc): Updated Efficacy and Safety Data
Gettinger, S., Bazhenova, L., Salgia, R., Langer, C., Gold, K., Rosell, R., Shaw, A., Weiss, G.J., Narasimhan, N.I., Dorer, D.J., Rivera, V.M., Clackson, T., Haluska, F.G., Camidge, R.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article